CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Stroke and transient ischaemic attack - Management
Drug treatments for secondary prevention of stroke, TIA, and other cardiovascular disease
- Antithrombotic, antihypertensive, and lipid modifying treatments are recommended, and will need to be started by the GP if this has not already been done in secondary care.
- For full management details, see the CKS topics on:
- All people should be followed up 1 month after the event, either in primary or secondary care, so that medication and other interventions to modify risk factors (for example diabetes, hypertension, hyperlipidaemia, or ischaemic heart disease) can be assessed [DH, 2007].
© NHS Institute for Innovation and Improvement